Regeneron Pharmaceuticals, Inc.

OPPENHEIMER ASSET MANAGEMENT INC. REGN

Report date

12/31/2025

Quarter

2025 Q4

Filed

2/2/2026

Shares

2,396

Value ($000)

1,849

Weight

0.0%

2019 Q4 - 2025 Q4 (20 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q4	2/2/2026	1,849	0.0%	2,396	12/31/2025
2025 Q3	11/6/2025	1,365	0.0%	2,428	9/30/2025
2025 Q2	7/31/2025	1,369	0.0%	2,608	6/30/2025
2025 Q1	4/23/2025	1,246	0.0%	1,965	3/31/2025
2023 Q3	11/8/2023	622	0.0%	756	9/30/2023
2023 Q2	8/3/2023	527	0.0%	734	6/30/2023
2023 Q1	5/10/2023	591	0.0%	719	3/31/2023
2022 Q4	2/7/2023	563	0.0%	781	12/31/2022
2022 Q3	11/14/2022	687	0.0%	997	9/30/2022
2022 Q2	8/8/2022	624	0.0%	1,056	6/30/2022
2022 Q1	5/12/2022	669	0.0%	958	3/31/2022
2021 Q4	2/2/2022	1,767	0.0%	2,799	12/31/2021
2021 Q3	11/12/2021	1,746	0.0%	2,887	9/30/2021
2021 Q2	8/3/2021	1,435	0.0%	2,569	6/30/2021
2021 Q1	5/17/2021	1,111	0.0%	2,347	3/31/2021
2020 Q4	2/11/2021	12,421	0.2%	25,710	12/31/2020
2020 Q3	11/13/2020	13,834	0.3%	24,713	9/30/2020
2020 Q2	8/11/2020	15,328	0.3%	24,577	6/30/2020
2020 Q1	5/8/2020	11,338	0.3%	23,220	3/31/2020
2019 Q4	2/7/2020	181	0.0%	481	12/31/2019